A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Public ClinicalTrials.gov record NCT05914805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-month Single-Blind Treatment With Clascoterone or Vehicle Solution
Study identification
- NCT ID
- NCT05914805
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cassiopea SpA
- Industry
- Enrollment
- 762 participants
Conditions and interventions
Conditions
Interventions
- Clascoterone 5% solution Drug
- Vehicle solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 16, 2023
- Primary completion
- Jul 15, 2025
- Completion
- Jul 15, 2025
- Last update posted
- Dec 21, 2025
2023 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigate MD | Scottsdale | Arizona | 85255 | — |
| Physician's Institute of Cosmetic and Reconstructive Surgery | Hollywood | Florida | 33021 | — |
| DelRicht Research | Atlanta | Georgia | 30329 | — |
| Revival Research Institute | Troy | Michigan | 48084 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| DelRicht Research | Wildwood | Missouri | 63040 | — |
| Piedmont Plastic Surgery and Dermatology | Huntersville | North Carolina | 28078 | — |
| Advanced Dermatology & Cosmetic Surgery | Spartanburg | South Carolina | 29307 | — |
| DelRicht Research | Thompson's Station | Tennessee | 37179 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Acclaim Dermatology LLC | Sugar Land | Texas | 77479 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05914805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05914805 live on ClinicalTrials.gov.